latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Wall Street Cheat Street
Sat, 04/27/13 - 10:10 am
Seeking Alpha
Wed, 04/24/13 - 4:46 pm
TheStreet.com
Tue, 04/02/13 - 10:58 am
tags: AbbVie, Achillion, Aegerion, Amarin, Arena Pharmaceuticals, AstraZeneca, Aveo Pharmaceutical, Biogen Idec, Bristol-Myers Squibb, Delcath, Dendreon, Depomed, Gilead, GSK, Merck, NewLink Genetics, Raptor Pharmaceuticals, Rigel, Sangamo BioSciences, Sucampo, Titan Pharmaceuticals, Valeant Pharmaceuticals, Vertex Pharmaceuticals, Vivus, Zogenix
Bizjournals.com
Thu, 03/07/13 - 12:35 pm
Motley Fool
Mon, 03/04/13 - 11:46 am
tags: Aegerion, Breo Ellipta, COPD, Depomed, FDA, GSK, Sarepta, Serada, Theravance
The Motley Fool
Sat, 01/19/13 - 1:12 pm
tags: Aegerion, Astra Zeneca, cancer, Isis Pharmaceuticals, treatment
TheStreet.com
Wed, 01/02/13 - 1:18 pm
Motley Fool
Tue, 01/01/13 - 12:53 pm
tags: Aegerion, Alnylam, Isis Pharmaceuticals, Juxtapid, Kynamro, Lipitor, PCSK9 inhibitors, Pfizer, Regeneron, Sanofi
Yahoo/AP
Mon, 12/24/12 - 11:30 am
Motley Fool
Sat, 12/15/12 - 1:54 pm
Seeking Alpha
Wed, 10/24/12 - 10:58 am
Motley Fool
Sun, 10/21/12 - 10:47 am
Seeking Alpha
Fri, 10/19/12 - 10:57 am
TheStreet.com
Thu, 10/18/12 - 11:39 am
Last 30 twitter posts
-
DTN Pharma News: Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences:... t.co/7E1cdXBUC4
-
#daytrading Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcomi... t.co/R741iA4sqE #pennystocks #money
-
$AEGR Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upco.. t.co/VKOKVxlUmO
-
How Scripted Aegerion Pharmaceuticals, Inc.'s Success Story t.co/7eSi50rQ5z #pharma
-
RT @bradloncar: $SRPT up 4.46%, receives > 85 tweet mentions. $AEGR up 4.86%, receives < 10. Don't understand why more people don't follow Aegerion.
-
$SRPT up 4.46%, receives > 85 tweet mentions. $AEGR up 4.86%, receives < 10. Don't understand why more people don't follow Aegerion.
-
FDA Approves Aegerion’s lomitapide (Juxtapid) for Homozygous Familial Hypercholesterolemia t.co/anDTmIEjFf
-
Job opportunity: Executive Director, Corporate Controller at Aegerion Pharmaceuticals - Greater Boston Area #jobs t.co/kbLwpweMHW
-
How Scripted Aegerion Pharmaceuticals, Inc.'s Success Story: Staying up-to-date has never been simpler. Sign ... t.co/tm7UAyPfrF
-
How Scripted Aegerion Pharmaceuticals, Inc.'s Success Story: Staying up-to-date has never been simpler. Sign ... t.co/GYL4NUfjnC
-
Aegerion <b>Pharmaceuticals</b> Price Target Raised to $50.00 at Jefferies Group <b>...</b> t.co/rgOmQv9yvk
-
RT @forbes_india: How Marc Beer Scipted Aegerion Pharma's Success Story t.co/cuYq1jP2ax
-
FDA Approves Aegerion’s lomitapide (Juxtapid) for Homozygous Familial Hypercholesterolemia t.co/anDTmIEjFf
-
How Marc Beer Scipted Aegerion Pharma's Success Story - Forbes India t.co/qfmijG7Y1c
-
How Marc Beer Scipted Aegerion Pharma's Success Story t.co/cuYq1jP2ax
-
FDA Approves Aegerion’s lomitapide (Juxtapid) for Homozygous Familial Hypercholesterolemia t.co/zHPi5d8Nxy
-
Great article - How CEO Marc Beer Scipted #OrphanDrug Co. Aegerion Pharma's Success Story #RareDisease t.co/4VZXVUFNxF
-
t.co/nAR45suIcN How Marc Beer Scipted Aegerion Pharma's Success Story - Forbes India t.co/oubQChmvoT
-
How Marc Beer Scipted Aegerion Pharma's Success Story t.co/4FSIgGbsQ9
-
How Marc Beer Scipted Aegerion Pharma's Success Story t.co/NnRSvrnDbc
-
Aegerion Pharmaceuticals Inc [$AEGR] locks 4.63 of downside variance - t.co/Ph0dx6sD1O t.co/cB1Zsz0Jhy
-
Aegerion's Pricing Power Sends Shares Flying t.co/ZSL1kPXcHO $ISIS $AEGR
-
Aegerion's Pricing Power Sends Shares Flying t.co/8yDap47aX7
-
Aegerion’s Pricing Power Sends Shares Flying t.co/ZmbqUySVeA
-
LONG #Stocks Ideas Aegerion's Pricing Power Sends Shares Flying: By Brian L. Wilson:Shares o... t.co/alHTU67782 #trading #MKT #Fx
-
DTN Pharma News: Aegerion's Pricing Power Sends Shares Flying: t.co/eTEQkKRuWh
-
Aegerion's Pricing Power Sends Shares Flying t.co/7Bc2bBUKck $ISIS $AEGR
-
Aegerion stock soars on price boost for cholesterol drug, Juxtapid - Boston Business Journal t.co/2AAlm9ROSr
-
PERFORMING BIOTECHNOLOGY and DRUGS COMPANIES: Aegerion ... - SBWire (press release) t.co/ZIQ06CGC9l
-
Fool not as impressed with Aegerion as others are t.co/jRiKxrtStd via @themotleyfool
